Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ClinicalTrials.gov 24,857 recruiting now free trial finder

Find a clinical trial that's recruiting now

Search 24,857 actively recruiting US clinical trials by condition, drug, or state, each entry links straight to its NIH ClinicalTrials.gov record so you can check eligibility and contact the study team.

24,857
trials recruiting now
14%
of all US trials open to enrollment
52
states with recruiting sites

A trial is listed as recruiting when its sponsor has marked it open to new participants on the public registry. Type a condition or drug name (for example, "breast cancer" or "pembrolizumab") to narrow the list, and add a state to find studies with a site near you. Results are ordered with the most relevant recruiting studies first; each card shows the study phase and enrollment target, and opens the full record, including eligibility criteria and contact details, on ClinicalTrials.gov.

100 trials found

Recruiting 999,999 target

Integrated Cancer Repository for Cancer Research

University of Nebraska

NCT02012699

Recruiting 100,000 target

International Weight Control Registry

Tufts University

NCT04907396

Recruiting 40,000 target

Stroke Thrombectomy and Aneurysm Registry

Medical University of South Carolina

NCT04994756

Recruiting 40,000 target

Registry Study for Radiation Therapy Outcomes

Proton Collaborative Group

NCT01255748

Recruiting 20,000 target

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Freenome Holdings

NCT06122077

Recruiting 20,000 target

Pancreatic Cancer Early Detection Consortium

Arbor Research Collaborative for Health

NCT04970056

Recruiting Phase 3 11,000 target

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

Boehringer Ingelheim

NCT06531824

Recruiting 10,000 target

Tracking Results of Ablations to Combat AF Registry Generation 2

AtriCure

NCT05111015

Recruiting NA 6,000 target

A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

McMaster University

NCT03127631

Recruiting NA 5,100 target

Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

Population Health Research Institute

NCT05701358

Recruiting Phase 2 5,000 target

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

QuantumLeap Healthcare Collaborative

NCT01042379

Recruiting 5,000 target

HS Students Mandatory Universal Student Instruction in CPR Appraised Learning- Is the Mandate Working?

Kansas City Heart Rhythm Research Foundation

NCT04493970

Recruiting 5,000 target

The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry

Yale University

NCT06030063

Recruiting 5,000 target

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Duke University

NCT04278404

Recruiting 5,000 target

Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry

University of Colorado, Denver

NCT05052606

Recruiting 5,000 target

CureDuchenne Link®: A Resource for Research

CureDuchenne

NCT04972604

Recruiting 4,500 target

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

Michael J. Fox Foundation for Parkinson's Research

NCT04477785

Recruiting 4,400 target

Blue Light Cystoscopy With Cysview® Registry

Photocure

NCT02660645

Recruiting NA 4,000 target

The Fourth Left Atrial Appendage Occlusion Study

Hamilton Health Sciences Corporation

NCT05963698

Recruiting 4,000 target

American Lung Association (ALA) Lung Health Cohort

Johns Hopkins University

NCT04543461

Recruiting Phase 3 4,000 target

Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49

Vaxcyte

NCT07284654

Recruiting NA 4,000 target

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

University of British Columbia

NCT04634240

Recruiting Phase 4 3,200 target

Individualizing Treatment for Asthma in Primary Care (Full Study)

DARTNet Institute

NCT07052942

Recruiting 3,000 target

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Duke University

NCT01915511

Recruiting 3,000 target

Real World Registry for Use of the Ion Endoluminal System

Intuitive Surgical

NCT06004440

Recruiting 3,000 target

High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer

Carol Fabian, MD

NCT00291096

Recruiting Phase 1 3,000 target

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

Beat AML

NCT03013998

Recruiting 3,000 target

Pulmonary Hypertension Association Registry

Pulmonary Hypertension Association

NCT04071327

Recruiting NA 2,500 target

Study of Student Flourishing

Flourish Science

NCT07259746

Recruiting 2,400 target

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Veracyte

NCT06426628

Recruiting Phase 4 2,000 target

Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

University of Rochester

NCT06964464

Recruiting 2,000 target

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

University of Kansas Medical Center

NCT06425848

Recruiting Phase 3 2,000 target

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Regeneron Pharmaceuticals

NCT07213778

Recruiting 2,000 target

Measuring Surgical Recovery After Radical Cystectomy

M.D. Anderson Cancer Center

NCT03193970

Recruiting 1,800 target

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Exact Sciences Corporation

NCT06401421

Recruiting NA 1,750 target

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Endotronix

NCT05934487

Recruiting Phase 3 1,700 target

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

Boehringer Ingelheim

NCT06238622

Recruiting 1,650 target

Prospective Study to Assess a Diagnostic Aid for Cancer

Harbinger Health

NCT07046260

Recruiting 1,600 target

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

Bristol-Myers Squibb

NCT05489705

Recruiting 1,500 target

ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

Alnylam Pharmaceuticals

NCT04561518

Recruiting 1,500 target

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

University of Kansas Medical Center

NCT02302742

Recruiting 1,500 target

Complex Adult Deformity Surgery (CADS)

International Spine Study Group Foundation

NCT04194138

Recruiting 1,500 target

An International Observational Study of Adults With Acute Infection

University of Minnesota

NCT07069400

Recruiting Phase 2 1,500 target

Pan Tumor Rollover Study

Bristol-Myers Squibb

NCT03899155

Recruiting 1,500 target

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

Incyte Corporation

NCT05919511

Recruiting Phase 1 1,405 target

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age

ModernaTX

NCT05992935

Recruiting Phase 2 1,400 target

LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

North American Consortium for Histiocytosis

NCT02205762

Recruiting Phase 3 1,400 target

CAR-T Long Term Follow Up (LTFU) Study

Novartis Pharmaceuticals

NCT02445222

Recruiting NA 1,316 target

The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)

MeMed Diagnostics

NCT05762302

Recruiting Phase 3 1,300 target

A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age

Vaxcyte

NCT07365826

Recruiting Phase 3 1,275 target

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Novartis Pharmaceuticals

NCT07225504

Recruiting Phase 3 1,250 target

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Alnylam Pharmaceuticals

NCT07052903

Recruiting Phase 3 1,216 target

A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

Bristol-Myers Squibb

NCT05827016

Recruiting NA 1,205 target

Prevail Global Study

Medtronic Vascular

NCT06535854

Recruiting Phase 3 1,200 target

Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Kailera

NCT07284979

Recruiting 1,200 target

Clinical Procedures to Support Research in ALS

University of Miami

NCT03489278

Recruiting 1,200 target

Nephrotic Syndrome Study Network

University of Michigan

NCT01209000

Recruiting Phase 1 1,130 target

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Revolution Medicines

NCT06445062

Recruiting NA 1,100 target

IMPRoving Outcomes in Vascular DisEase - Aortic Dissection

Duke University

NCT06087029

Recruiting Phase 3 1,046 target

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

Merck Sharp & Dohme

NCT06717347

Recruiting NA 1,024 target

iAmHealthy Clinical Practice Guideline (CPG)

University of Kansas Medical Center

NCT06888011

Recruiting 1,000 target

HER2-positive Breast Cancer Registry

Priyanka Sharma

NCT06603597

Recruiting 1,000 target

Abbott DBS Post-Market Study of Outcomes for Indications Over Time

Abbott Medical Devices

NCT04071847

Recruiting 1,000 target

Interstitial Lung Disease Research Unit Biobank

University of Kansas Medical Center

NCT05392881

Recruiting 1,000 target

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

United Therapeutics

NCT06388421

Recruiting 1,000 target

One-Time DNA Study for Vasculitis

University of Pennsylvania

NCT01241305

Recruiting 1,000 target

Deep Functional Phenotyping of the ALA Lung Health Cohort

Johns Hopkins University

NCT06177717

Recruiting 1,000 target

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

University of Kansas Medical Center

NCT03413982

Recruiting 1,000 target

Mitral Valve Screening Survey

Medstar Health Research Institute

NCT04736667

Recruiting Phase 3 1,000 target

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Bristol-Myers Squibb

NCT06561386

Recruiting 1,000 target

SuperSaturated Oxygen Comprehensive Observational Registry

TherOx

NCT06438315

Recruiting 1,000 target

Abbott Cephea Mitral Valve Disease Registry

Abbott Medical Devices

NCT07069673

Recruiting 1,000 target

Global Paradise System US Post Approval Study

ReCor Medical

NCT06297291

Recruiting Phase 3 990 target

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine

Merz Therapeutics

NCT07018700

Recruiting Phase 3 975 target

A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)

Merck Sharp & Dohme

NCT07216482

Recruiting Phase 3 960 target

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

Celgene

NCT06764485

Recruiting NA 960 target

SELUTION 4 De Novo Small Vessel IDE Trial

M.A. Med Alliance S.A.

NCT05946629

Recruiting Phase 2 956 target

Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

BicycleTx Limited

NCT06225596

Recruiting Phase 3 940 target

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Novartis Pharmaceuticals

NCT06855277

Recruiting Phase 2 900 target

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Astellas Pharma Global Development

NCT02960022

Recruiting Phase 3 900 target

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Eli Lilly and Company

NCT07353931

Recruiting NA 900 target

MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms

CooperVision

NCT05285553

Recruiting Phase 3 892 target

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

GlaxoSmithKline

NCT05855200

Recruiting Phase 3 882 target

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Janssen Research & Development

NCT07196748

Recruiting NA 850 target

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Abbott Medical Devices

NCT06526195

Recruiting Phase 2 840 target

Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

AbbVie

NCT06236438

Recruiting Phase 3 830 target

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

AstraZeneca

NCT06868277

Recruiting Phase 3 815 target

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

Merck Sharp & Dohme

NCT07218029

Recruiting Phase 3 810 target

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Celgene

NCT05519085

Recruiting Phase 3 800 target

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

TG Therapeutics

NCT05877963

Recruiting Phase 3 800 target

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

Eli Lilly and Company

NCT07153471

Recruiting Phase 3 800 target

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Janssen Research & Development

NCT07225946

Recruiting Phase 3 780 target

A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

BeiGene

NCT05100862

Recruiting Phase 3 780 target

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

Merz Therapeutics

NCT07018713

Recruiting Phase 3 777 target

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

SWOG Cancer Research Network

NCT05642611

Recruiting Phase 1 764 target

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Genmab

NCT05579366

Recruiting Phase 2 744 target

Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells

Bavarian Nordic

NCT07199569

Recruiting Phase 2 740 target

Optimizing Reperfusion to Improve Outcomes and Neurologic Function

Corxel Pharmaceuticals

NCT06990867

Recruiting Phase 3 734 target

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

NovoCure

NCT06216301

Recruiting Phase 2 728 target

Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

DiaMedica Therapeutics

NCT05065216

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Recruiting status is reported by each study's sponsor and mirrored from the public registry. Always confirm current eligibility and status on ClinicalTrials.gov before contacting a study.

Verify with NIH →